SAL-0951 tablets
Sponsors
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Conditions
Anemia
Phase 3
Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialysis
CompletedNCT06720233
Start: 2002-02-22End: 2024-10-28Updated: 2024-12-06
Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance Hemodialysis
CompletedNCT06720025
Start: 2023-09-19End: 2024-06-20Updated: 2024-12-06